Review Articles

  1. Research
  2. Review Articles
  3. Review Articles
211
Bansal AK.. Product development issues of powders for injection. Pharmaceutical Technology 2002, 26 , 122-132.
212
Gupta P, Vermani K and Garg S.. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discovery Today 2002, 7 , 569-579.
213
Jayanarayan KG and Dey CS.. Microtubules: Dynamics, drug interaction and drug resistance in Leishmania. Journal of Clinical Pharmacy and Therapeutics 2002, 27 , 313-320.
214
Singh S, Rao KVR, Venugopal K and Manikandan R.. Alteration in dissolution characteristics of gelatin-containing formulations: a review of the problem, test methods, and solutions. Pharmaceutical Technology 2002, 26 , 36-58.
215
Thiyagarajan M.. α-Adrenoceptor antagonists in the treatment of benign prostate hyperplasia. Pharmacology 2002, 65 , 119-128.
216
Verma RK, Krishna DM and Garg S.. Formulation aspects in the development of osmotically controlled oral drug delivery systems. Journal of Controlled Release 2002, 79 , 27-7.
217
Vermani K and Garg S.. Herbal medicines for sexually transmitted diseases and AIDS. Journal of Ethnopharmacology 2002, 80 , 49-66.
218
Agrawal S, Thomas NS, Dhanikula AB, Kaul CL and Panchagnula R.. Antituberculosis drugs and new drug development. Current Opinion in Pulmonary Medicine 2001, 7 , 142-147.
219
Garg A, Garg S, Zaneveld L and Singla A.. An update on the chemistry and pharmacology of the citrus bioflavanoid-hesperidin. Phytotherapy Research 2001, 15 , 655-669.
220
Kaul CL and Ramarao P.. The role of aldose reductase inhibitors in diabetic complications: recent trends. Methods and Findings in Experimental and Clinical Pharmacology 2001, 23 , 465-475.
221
Panchagnula R, Agrawal S and Kaul CL.. Fixed dose combinations in treatment of tuberculosis. Indian Journal of Pharmaceutical Sciences 2001, 63 , 9-1.
222
Pillai O and Panchagnula R.. Polymers in drug delivery. Current Opinion in Chemical Biology 2001, 5 , 447-451.
223
Pillai O, Dhanikula AB and Panchagnula R.. Drug delivery: an odyssey of 100 years. Current Opinion in Chemical Biology 2001, 5 , 439-446.
224
Pillai O, Nair V, Jain AK, Thomas NS and Panchagnula R.. Noninvasive transdermal delivery of peptides and proteins. Drugs of the future 2001, 26 , 779-791.
225
Singh S, Mariappan TT, Shankar R, Sharda N and Singh B.. A critical review of the probable reasons for the poor variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem. International Journal of Pharmaceutics 2001, 228 , 17-5.
Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

243|15|15